Observational studyInternational journal of clinical oncology2019

Bevacizumab combined with platinum-taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial).

Shinichi Komiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.